Allergan’s New Chairman of the Board

November 1, 2016

Brenton L. Saunders is Allergan’s new Chairman of the Board, the company reports.
Effective today, Saunders will replace Paul Bisaro, who served as Executive Chairman since July 1, 2014.  Bisaro will remain a member of the Allergan Board of Directors.  In addition to the role of Chairman, Saunders will retain his current role as Chief Executive Officer and President.  Also, effective today, Christopher Coughlin has been elected Lead Independent Director.
Saunders has served as a member of Allergan’s Board of Directors and as Chief Executive Officer and President since July 2014. He was previously Chief Executive Officer and President of Forest Laboratories and a member of the Board of Directors of Forest. He is currently a member of the Board of Trustees of the University of Pittsburgh, The Business Council and PhRMA.
Read More >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Approves Belotero Volume and Belotero Intense
    • Ad IntellX Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform
    • TITAN Aesthetic Founder Mary Beth Hagen Transfers Ownership to Carrie Galpin
    • AmSpa’s Medical Spa Show Voted Best Tradeshow Injectable Education